US scrutiny, UK ramifications: pharma pricing in the political spotlight

Pharma companies and their approach to pricing are back in the political spotlight. While there are major differences between US parties on most issues, the debate on drug pricing has united them as last week top executives from seven major pharmaceutical companies were called to testify in front of Congress. A combative session lasted severalRead more

Pharmaceutical pricing: who holds the cards now?

Negotiations between NHS England and Vertex over access to vital CF drugs have reached an impasse. Both sides appear to have dug their heels into the ground, with patients and politicians left frustrated at the prospect of yet more delays. Some are increasingly despondent over the prospect that a deal may never be reached. TheRead more

Matt Hancock – who is the new Health Secretary?

  Ambitious Now the youngest person in the Cabinet, Hancock’s rise has been swift – from Special Advisor to George Osborne, to MP, to Minister, and then Secretary of State in the course of only 13 years. This is, in fact, his eighth ministerial post since 2013. But his further ambitions are well known inRead more